AVROBIO Operating Expenses 2011-2026 | AVRO

Annual Operating Expenses AVROBIO

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
71.7 M	105 M	119 M	120 M	75.8 M	46.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
120 M	46.2 M	89.7 M

Quarterly Operating Expenses AVROBIO

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21.9 M	22.3 M	18.3 M	-	19.6 M	11.4 M	13 M	-	10.1 M	10.6 M	25.2 M	-	23 M	27.8 M	29.4 M	-	32.6 M	31.4 M	26.9 M	-	36.7 M	28.9 M	26.6 M	-	18.1 M	16.6 M	17.7 M	-	12.2 M	9.55 M	7.79 M	-	6.37 M	2.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.7 M	2.54 M	19.5 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Alector ALEC	177 M	$ 2.12	-12.96 %	$ 218 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	103 M	$ 4.24	-1.62 %	$ 301 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	77 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Agenus AGEN	46 M	$ 3.34	0.15 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	543 M	$ 28.71	-5.03 %	$ 1.66 B	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Фармсинтез LIFE	201 M	-	-	-	Russia